drugset / Trial / NCT01214395

Nasal Tea Tree Oil for the Prevention of Infections in PD Patients

NCT01214395

Phase 2 Completed 5 enrolled PathWest Laboratory Medicine WA
NaSingle-groupOpen-labelPrevention

Summary

This study will compare the use of tea tree oil as a topical nasal antiseptic to prevent infections in patients that need renal dialysis. A maximum of fifty subjects will be recruited and will be assessed for signs of infection once per week for the first 6 weeks and then every 4 weeks until week 26. They will also be checked for nasal carriage of 'Golden Staph' when they enroll in the trial. The subjects will complete the trial if they have 26 weeks infection-free or if they have an infection during that period

Timeline

Start
2010-06
Primary completion
2011-11
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject tea tree oil Unknown 5 % Intranasal